ALK

CROWN study: lorlatinib vs crizotinib in 1L NSCLC 5:28
CROWN study: lorlatinib vs crizotinib in 1L NSCLC
Sanjay Popat
ALTA-1L updates at ESMO 2020: intracranial efficacy and HRQoL 3:41
ALTA-1L updates at ESMO 2020: intracranial efficacy and HRQoL
Sanjay Popat
Updates in ALK+ NSCLC 10:43
Updates in ALK+ NSCLC
Ross Camidge
Management of frontline ALK+ NSCLC: brigatinib vs. alectinib 3:04
Management of frontline ALK+ NSCLC: brigatinib vs. alectinib
Riyaz Shah
Brain metastases in ALK+ NSCLC 2:35
Brain metastases in ALK+ NSCLC
Natasha Leighl
UK excels at molecular testing for lung cancer 0:51
UK excels at molecular testing for lung cancer
Riyaz Shah
Lung cancer molecular testing in the UK 4:38
Lung cancer molecular testing in the UK
Neal Navani
Lung cancer: actionable targets 4:16
Lung cancer: actionable targets
Samreen Ahmed
Current treatment landscape for ALK-positive NSCLC 2:21
Current treatment landscape for ALK-positive NSCLC
Marina Garassino
Biomarkers in NSCLC: a pathologist’s insight into PD-L1 and TMB 3:43
Biomarkers in NSCLC: a pathologist’s insight into PD-L1 and TMB
Alex Haragan
Challenges and treatment of CNS metastases in NSCLC 0:58
Challenges and treatment of CNS metastases in NSCLC
Sanjay Popat
Impact of new TKIs on NSCLC treatment planning 3:16
Impact of new TKIs on NSCLC treatment planning
Nicolas Girard
Optimizing treatment of ALK+ NSCLC: clinical realities 1:23
Optimizing treatment of ALK+ NSCLC: clinical realities
Silvia Novello
Therapy sequencing in the current NSCLC treatment landscape 1:34
Therapy sequencing in the current NSCLC treatment landscape
Nicolas Girard
Personalized therapy in thoracic malignancies 1:34
Personalized therapy in thoracic malignancies
Dean Fennell
A new role for pharmacists in the personalized treatment of cancer patients? 4:43
A new role for pharmacists in the personalized treatment of cancer patients?
Christine Walko
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals